29 Downloads (Pure)

Abstract

The treatment goal in type 2 diabetes (T2D) is to keep the blood glucose within a target range. In the early stages of diabetes, the treatment may consist entirely of oral antidiabetics (OAD), which may be preferable over injectables for some people. However, previously published systematic reviews found a low OAD adherence and that the adherence differs between different OAD types. These systematic reviews were performed before 2015, and several new OADs have been marketed since then. Thus, a systematic review will be undertaken to review the newest studies on adherence to oral second line antidiabetics in people with T2D.
OriginalsprogEngelsk
TitelProceedings of the 18th Scandinavian Conference on Health Informatics
ForlagLinköping University Electronic Press
Publikationsdatoaug. 2022
Sider208-209
ISBN (Elektronisk)978-91-7929-344-4
DOI
StatusUdgivet - aug. 2022
BegivenhedThe Scandinavian Conference on Health Informatics (SHI) 2022 - Tromsø, Norge
Varighed: 22 aug. 202224 aug. 2022

Konference

KonferenceThe Scandinavian Conference on Health Informatics (SHI) 2022
Land/OmrådeNorge
ByTromsø
Periode22/08/202224/08/2022
NavnScandinavian conference on health informatics
ISSN1650-3686

Fingeraftryk

Dyk ned i forskningsemnerne om 'The Adherence to Oral Second Line Antidiabetic Medication in People with Type 2 Diabetes: A Protocol for a Systematic Review'. Sammen danner de et unikt fingeraftryk.

Citationsformater